Navigation Links
Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
Date:2/26/2008

LAKE FOREST, Ill., Feb. 26 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global hospital products company, today announced a new national agreement with HealthTrust Purchasing Group, LP (HealthTrust). The multi-year contract will provide HealthTrust member organizations with access, on a non-exclusive basis, to Hospira's general-purpose medication infusion devices, related sets and disposables, along with intravenous (I.V.) solutions, nutritionals and drug-delivery products.

Through existing agreements, Hospira already provides pain-management infusion pumps to HealthTrust members, and infusion devices, I.V. solutions and equipment to members of Consorta -- a group purchasing organization (GPO) that joined HealthTrust in 2007.

"Hospira's products and services can help HealthTrust's members meet their goals -- from increasing patient safety to reducing costs and improving caregiver productivity," said Pete Baker, vice president and general manager, Commercial Service Operations, Hospira. "We look forward to developing strong relationships with HealthTrust's member healthcare institutions."

The new agreement includes Hospira's general-purpose medication infusion technologies, such as the Plum A+(R) and next-generation Symbiq(R) infusion systems with Hospira MedNet(R) safety software. These products play a critical role in improving patient safety as well as enhancing quality of care and clinician workflow. The contract also provides access to Hospira's I.V. solutions and associated equipment portfolio, including the company's more environmentally preferable VisIV(R) container for I.V. solutions. This contract represents the first opportunity for Hospira to provide access to these products to HealthTrust members.

About HealthTrust

HealthTrust Purchasing Group, headquartered in Brentwood, Tennessee, is a group purchasing organization that supports over 3800 not-for-profit and for-profit facilities, which include acute care hospitals, ambulatory surgery centers, physician practices, and alternate care sites. With an annual purchasing volume by its members of more than $13 billion, HealthTrust is committed to obtaining the best price for clinically-recommended products, ensuring their timely delivery and continuously evaluating and improving its services to the patients, physicians and clinicians it serves. HealthTrust is located at 155 Franklin Road, Suite 400, Brentwood, TN 37027 Website: http://www.healthtrustpg.com.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at http://www.hospira.com.
Private Securities Litigation Reform Act of 1995 --

A Caution Concerning Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Hospira cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological and other factors that may affect Hospira's operations and may cause actual results to be materially different from expectations include the risks and uncertainties set forth under the heading "Item 1 Business -- Risk Factors" in Hospira's Annual Report on Form 10-K for the year ended Dec. 31, 2006, filed with the Securities and Exchange Commission, which are incorporated by reference. Hospira undertakes no obligation to release publicly any revisions to forward-looking statements as the result of subsequent events or developments.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hospira Hosts Conference Call for Fourth-Quarter 2007 Results and 2008 Projections
2. Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9
3. Hospira Reports Third-Quarter 2007 Results
4. Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13
5. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
6. Thomson Healthcare Announces Enhancements to Order Sets Solution
7. Heska Announces Q4 and Annual 2007 Results
8. Acuo Technologies(R) Announces a Fully Integrated XDS-I Solution
9. The Quantum Group Announces Strategic Technology Alliance
10. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
11. China Bionanometer Industries Corporation Announces New Products for China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Bionic Sports Nutrition LLC, an American company ... it had a successful January ECRM Trade Show in Hilton Head, SC. , ... allows it to provide its products to all clients at reasonable prices. At the ...
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... ... and wellness products to enhance people’s everyday lives, recently attended the January ECRM ... buyers. , ATP Science is known for its large range of supplements that ...
(Date:1/20/2017)... florida (PRWEB) , ... January 20, 2017 , ... Michael ... the Dana Farber Cancer Institute. For Betsy, the clinical trial has been life-saving ... cancer has not worsened. , Betsy Brauser was diagnosed with ovarian cancer in ...
(Date:1/20/2017)... ... January 20, 2017 , ... Vitamin Well has launched ... The drinks have been produced in collaboration with Zlatan Ibrahimovic and have been ... , After a successful launch in Sweden last year, the next generation sports ...
(Date:1/20/2017)... ... ... “The Angel”: a heartwarming and earnest tale of faith and believing ... “The Angel” is the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, ... , When asked of her new book, Marjorie says, “‘The Angel’ was written as ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 ... ... Forecast 2016-2026: Opportunities for Leading Companies – our new ... new report discusses issues and events affecting the Alzheimer,s ... qualitative analyses to answer these key questions: - How ...
(Date:1/19/2017)... , Jan. 19, 2017  Stealth BioTherapeutics Inc. ... to treat mitochondrial dysfunction, today announced new additions to ... M.D., as Chief Medical Officer, and Daniel Geffken ... announced that Jim Carr , Pharm.D. has been ... "We are pleased to welcome Doug and Daniel to ...
(Date:1/19/2017)... Accuray Incorporated (Nasdaq: ARAY ) ... to set the bar for excellence in customer satisfaction. ... satisfaction rating among radiation treatment delivery systems in the ... Intelligence Briefing™. The most recent ratings trend also shows ... peers for 11 of the past 12 quarters. ...
Breaking Medicine Technology: